Download PDF
Thromb Haemost 2009; 102(01): 179-180
DOI: 10.1160/TH09-01-0037
Letters to the Editor
Schattauer GmbH

Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study

Dov Shiffman
1   Celera, Alameda, California, USA
,
Daniel I. Chasman
2   Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachussetts, USA
,
Christie M. Ballantyne
3   Section of Atherosclerosis and Vascular Medicine, Department of Medicine Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA
,
Vijay Nambi
3   Section of Atherosclerosis and Vascular Medicine, Department of Medicine Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA
,
James J. Devlin
1   Celera, Alameda, California, USA
,
Eric Boerwinkle
4   Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, Texas, USA
› Author Affiliations
Further Information

Publication History

Received: 15 January 2009

Accepted after minor revision: 21 April 2009

Publication Date:
24 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Luke MM, Kane JP, Liu DM. et al. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 2007; 27: 2030-2036.
    CrossrefPubMedGoogle Scholar
  • 2 Shiffman D, Kane JP, Louie JZ. et al. Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction. PLoS ONE 2008; 03: e2895.
    CrossrefPubMedGoogle Scholar
  • 3 Shiffman D, O’Meara ES, Bare LA. et al. Association of gene variants with incident myocardial infarction in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2008; 28: 173-179.
    PubMedGoogle Scholar
  • 4 Chasman DI, Shiffman D, Zee RYL. et al. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 2009; 203: 371-376.
    CrossrefPubMedGoogle Scholar
  • 5 Morrison AC, Bare LA, Chambless LE. et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2007; 166: 28-35.
    CrossrefPubMedGoogle Scholar